Mesenchymal stem cell transplantation for ischemic diseases: mechanisms and challenges

TT Van Nguyen, NB Vu, P Van Pham - Tissue Engineering and …, 2021 - Springer
Ischemic diseases are conditions associated with the restriction or blockage of blood supply
to specific tissues. These conditions can cause moderate to severe complications in …

Global stroke statistics 2023: Availability of reperfusion services around the world

J Kim, MT Olaiya, DA De Silva… - … Journal of Stroke, 2024 - journals.sagepub.com
Background: Disparities in the availability of reperfusion services for acute ischemic stroke
are considerable globally and require urgent attention. Contemporary data on the …

Outcome predictors in anterior and posterior ischemic strokes: a study based on the Iranian SITS registry

N Jalali, E Sadeghi Hokmabadi, A Ghoreishi… - Scientific reports, 2023 - nature.com
Ischemic stroke is the major form of stroke with two separate vascular territories. Many risk
factors are related to stroke outcomes in both territories. The present descriptive research …

[HTML][HTML] The risk factors of early hemorrhage after emergency intravenous thrombolysis in patients with acute ischemic stroke

X Zhang, Y Yu, L Jiang, T Chen, Y Sang… - Annals of Palliative …, 2021 - apm.amegroups.org
Background: At present, the treatment of acute ischaemic stroke (AIS) by aticepase (rt-PA) in
emergency veins has become the main treatment mode in hospital, but the research on …

Diagnosis of Early Neurological Deterioration after Intravenous Thrombolysis for Patients with Cerebral Ischemic Stroke Using Compressed Sensing‐Magnetic …

J Wang, B Wang, Y Tang, H Yan - Contrast Media & Molecular …, 2021 - Wiley Online Library
This study was to explore the risk factors and prognosis of early neurological deterioration
(END) after intravenous thrombolysis in patients with cerebral ischemic stroke (CIS) with the …

Compressed Sensing Algorithm‐Based Magnetic Resonance Imaging Guided for Prognosis of Early Neurological Deterioration after Intravenous Thrombolysis in …

Y Huang, X Sun, Y Yao, Y Chen, Y Chen… - Scientific …, 2021 - Wiley Online Library
This work was aimed to study the risk factors and prognostic treatment for acute ischemic
stroke (AIS) patients with early neurological deterioration (END) after intravenous …

The outcomes of mechanical thrombectomy in patients with acute stroke with and without intravenous injection of tissue plasminogen activator

M Khazaei, RM Mohammadi… - Biomedical …, 2022 - bmrat.biomedpress.org
Background: Stroke is a major health problem and leading cause of mortality worldwide.
This study aimed to evaluate the consequences of intravascular interventions in patients …

[HTML][HTML] Investigating Neutrophil-to-Lymphocyte Ratio and Risk Factors for Hemorrhagic Transformation Following Thrombolytic Therapy: Insights from a Cross …

N Farzan, A Khanmirzaei, M Ghodrati, H Mahmodi… - Archives of … - brieflands.com
Background: Hemorrhagic transformation (HT) is a serious complication of thrombolytic
therapy with recombinant tissue plasminogen activator (r-tPA) in patients with acute …

중간엽줄기세포(MSC) 를이용한허혈성혈관질환치료를위한세포치료제개발: 기초연구에서임상연구

이은지, 박신후, 서정호, 안효경, 남시현, 권상모 - 생명과학회지, 2022 - dbpia.co.kr
최근 인구 고령화로 인해 허혈성 심장질환, 허혈성 뇌졸중, 말초 동맥 질환 등의 허혈성
혈관질환의 유병률이 지속적으로 증가하고 있다. 허혈성 질환에 대한 현재 표준화된 치료법은 …

Development of Cell Therapeutics against Ischemic Vascular Diseases Using Mesenchymal Stem Cells: From Bench to Bed

EJ Lee, SH Park, JH Seo, HG An, SH Nam… - Journal of Life …, 2022 - koreascience.kr
Recently, the prevalence of ischemic diseases, such as ischemic heart disease, cerebral
ischemia, and peripheral arterial disease, has been continuously increasing due to the …